Fortis Healthcare
Indian multinational chain of private hospitals From Wikipedia, the free encyclopedia
Fortis Healthcare Limited (FHL) is an Indian for-profit private hospital network headquartered in Gurgaon. The company began its operations in Mohali, Punjab, where its first hospital was established. It later expanded by acquiring the healthcare division of Escorts Group, including the Escorts Heart and Research Center, Okhla, Delhi.
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
 | |
Fortis Hospital, Noida | |
| Company type | Public |
|---|---|
| BSE: 532843 NSE: FORTIS | |
| Industry | Healthcare |
| Founded | 1996 |
| Headquarters | , |
Area served | Worldwide |
Key people | Ravi Rajagopal (Chairman)[1] |
| Products | Hospitals, Pharmacy, Diagnostic centres |
| Revenue | ₹6,359 crore (US$740 million) (2023)[2] |
| ₹920 crore (US$110 million) (2023)[2] | |
| ₹611 crore (US$71 million) (2023)[2] | |
Number of employees | 23,000 (2023)[2] |
| Parent | IHH Healthcare (31.1%) |
| Website | www |
The Fortis Memorial Research Institute (FMRI) in Gurgaon serves as the headquarters for Fortis Healthcare.[3][4] In addition to its Gurgaon facility, Fortis Healthcare operates hospitals in the Delhi NCR, including locations in Faridabad, Noida, Vasant Kunj, and Shalimar Bagh, along with other facilities across India, Dubai, and Sri Lanka. The company currently manages 36 healthcare facilities.[5][6]
History
In 2018, Manipal Hospitals and TPG Capital offered to acquire Fortis Healthcare for ₹3,900 crore.[7][8][9] After a bidding war,[10] Malaysia's IHH Healthcare completed the acquisition of a 31.1% controlling stake for ₹4,000 crore. Representatives from IHH Healthcare were appointed to the Fortis board.[11]
In 2019, Fortis Healthcare announced the acquisition of RHT Health Trust (RHT) assets for an enterprise value of ₹4,650 crore.[12]
In August 2023, Fortis announced the completion of its acquisition of Medeor Hospital in Manesar from VPS Healthcare for $27.23 million.[13]
In 2024, Fortis Healthcare announced that it would acquire a 31% stake held by private equity firms in its diagnostics subsidiary, Agilus Diagnostics, for ₹1,780 crore.[14]
See also
References
External links
Wikiwand - on
Seamless Wikipedia browsing. On steroids.